Wedbush analyst Daniel Ives raised his price target for DocuSign (DOCU) to $80 from $65 saying that based on his positive Q3 checks, he believes the company is continuing to see strength in the field and is still in the early innings of capitalizing on an expanding deal pipeline both domestically as well as internationally. Further, the analyst things the brand awareness of DocuSign is "unparalleled in the market" from what he hears from customers/partners and has enabled the company to fend off potential competition thus far from all angles including Adobe (ADBE), which remains the biggest competitive/Street worry with "the bark being a lot worse than the bite."